Renaud Sabatier

83
Documents

Présentation

Department of Medical Oncology - Institut Paoli-Calmettes

CRCM - Centre de Recherche en Cancérologie de Marseille (Aix-Marseille Univ, CENRS, INSERM, Institut Paoli-Calmettes)

Publications

5
2
15
12
5
8
10
3
3
1
4
1
2
6
5
1
10
9
5
5
4
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
9
6
5
5
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Publications

Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies

Maria Kfoury , Pascal Finetti , Emilie Mamessier , François Bertucci , Renaud Sabatier
International Journal of Molecular Sciences, 2024, 25 (22), pp.11953. ⟨10.3390/ijms252211953⟩
Article dans une revue hal-04945209 v1

Endometrioid ovarian carcinoma landscape: pathological and molecular characterization

Alexandre de Nonneville , Elsa Kalbacher , Francesco Cannone , Arnaud Guille , José Adelaïde et al.
Molecular Oncology, 2024, ⟨10.1002/1878-0261.13679⟩
Article dans une revue hal-04933229 v1

Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25

Coline Montégut , Claire Falandry , Saverio Cinieri , Claire Cropet , Laure Montane et al.
Article dans une revue hal-05002859 v1
Image document

Decoding the pathological and genomic profile of epithelial ovarian cancer

Rim Rejaibi , Arnaud Guille , Maroua Manai , Jose Adelaide , Emilie Agavnian et al.
Scientific Reports, 2024, 14 (1), pp.28573. ⟨10.1038/s41598-024-80030-z⟩
Article dans une revue pasteur-05004059 v1

Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

Antonio González-Martín , María Jesús Rubio , Florian Heitz , René Depont Christensen , Nicoletta Colombo et al.
Journal of Clinical Oncology, 2024, 42 (36), pp.4294-4304. ⟨10.1200/JCO.24.00668⟩
Article dans une revue hal-05033891 v1
Image document

Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network

Elsa Nigon , Claudia Lefeuvre-Plesse , Alejandra Martinez , Céline Chauleur , Alain Lortholary et al.
Journal of Translational Medicine, 2023, 21 (1), pp.408. ⟨10.1186/s12967-023-04264-7⟩
Article dans une revue hal-04390892 v1

Real-world dostarlimab use in advanced/recurrent endometrial cancer in France

Manuel Rodrigues , Lauriane Eberst , Philippe Follana , Ludiane Gauthier , Virginie Jacquemin et al.
Bulletin du Cancer, 2023, 110 (10), pp.1041-1050. ⟨10.1016/j.bulcan.2023.06.009⟩
Article dans une revue hal-05046854 v1

The safety and efficacy of palbociclib in older patients with advanced breast cancer in a real-world setting

Etienne Gouton , Louis Tassy , Joelle Micallef , Amir Meskine , Renaud Sabatier et al.
JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8, ⟨10.20517/2394-4722.2022.64⟩
Article dans une revue hal-04085342 v1
Image document

Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort

Quentin Dominique Thomas , Amal Boussere , Jean-Marc Classe , Christophe Pomel , Hélène Costaz et al.
Gynecologic Oncology, 2022, 167 (1), pp.11-21. ⟨10.1016/j.ygyno.2022.08.005⟩
Article dans une revue hal-03868125 v1

Développement des infirmiers en pratique avancée en oncologie et hémato-oncologie en France : état des lieux précoce

Catherine Karine Evans , Renaud Sabatier , Olivier Chinot , Alain Loschi , Sylvie Arnaud et al.
Bulletin du Cancer, 2022, 109 (2), pp.139-150. ⟨10.1016/j.bulcan.2021.11.009⟩
Article dans une revue hal-03622825 v1
Image document

L’année 2021 dans tous ses états : une synthèse digérée

Jacques-Olivier Bay , Carole Bouleuc , Nelly Firmin , Virginie Gandemer , Nicolas Magne et al.
Bulletin du Cancer, 2022, 109 (1), pp.8-19. ⟨10.1016/j.bulcan.2021.12.003⟩
Article dans une revue hal-03622801 v1

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

Ana Oaknin , Lucy Gilbert , Anna Tinker , Jubilee Brown , Cara Mathews et al.
Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003777. ⟨10.1136/jitc-2021-003777⟩
Article dans une revue hal-03622811 v1
Image document

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study

Renaud Sabatier , Cécile Vicier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia et al.
Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩
Article dans une revue hal-03583253 v1
Image document

Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network

Clémence Romeo , Olivia Le Saux , Margaux Jacobs , Florence Joly , Gwenael Ferron et al.
Cancers, 2022, 14 (2), pp.354. ⟨10.3390/cancers14020354⟩
Article dans une revue hal-03622814 v1
Image document

Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network

Clémence Romeo , Olivia Le Saux , Margaux Jacobs , Florence Joly , Gwenael Ferron et al.
Cancers, 2022, 14 (2), pp.354. ⟨10.3390/cancers14020354⟩
Article dans une revue hal-05031280 v1
Image document

Évolution et facteurs associés à la publication des travaux de thèse d’exercice par les internes d’oncologie médicale en France

Alexandre de Nonneville , F. Bertucci , Éric Lambaudie , Gilles Houvenaeghel , Renaud Sabatier et al.
Bulletin du Cancer, 2022, ⟨10.1016/j.bulcan.2022.01.009⟩
Article dans une revue hal-03623519 v1
Image document

Développement des infirmiers en pratique avancée en oncologie et hémato-oncologie en France : état des lieux précoce

Catherine Evans , Catherine Karine Evans , Renaud Sabatier , Olivier Chinot , Alain Loschi et al.
Bulletin du Cancer, 2022, 109 (2), pp.139-150. ⟨10.1016/j.bulcan.2021.11.009⟩
Article dans une revue hal-03598884 v1
Image document

Actualités 2021 sur le cancer du sein localement avancé ou métastatique RH+/HER2−

Essia Mezni , Renaud Sabatier , Anthony Goncalves , Cécile Vicier
Bulletin du Cancer, 2022, 109 (2), pp.216-225. ⟨10.1016/j.bulcan.2021.12.009⟩
Article dans une revue hal-03622806 v1
Image document

Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial

Renaud Sabatier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia , Jihane Pakradouni et al.
Frontiers in Oncology, 2022, 12, pp.946257. ⟨10.3389/fonc.2022.946257⟩
Article dans une revue hal-04081622 v1

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial

Émilien Billon , Gwenaelle Gravis , Arnaud Guille , Nadine Carbuccia , José Adélaïde et al.
Cancers, 2022, 14 (9), ⟨10.3390/cancers14092275⟩
Article dans une revue hal-04085310 v1
Image document

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario

Leonel Varela Cagetti , Christophe Zemmour , Eric Lambaudie , Magalie Provansal , Renaud Sabatier et al.
Journal of Contemporary Brachytherapy, 2022, 14 (4), pp.321 - 331. ⟨10.5114/jcb.2022.118831⟩
Article dans une revue inserm-04053267 v1

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

François-Clément Bidard , Anne-Claire Hardy-Bessard , Florence Dalenc , Thomas Bachelot , Jean-Yves Pierga et al.
Lancet Oncology, 2022, 23 (11), pp.1367-1377. ⟨10.1016/S1470-2045(22)00555-1⟩
Article dans une revue hal-03867802 v1
Image document

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology

Sandrine Rousset-Rouviere , Philippe Rochigneux , Anne-Sophie Chrétien , Stéphane Fattori , Laurent Gorvel et al.
Biomedicines, 2021, 9 (6), pp.632. ⟨10.3390/biomedicines9060632⟩
Article dans une revue hal-03622756 v1
Image document

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

François Bertucci , Anthony Gonçalves , Arnaud Guille , José Adelaïde , Séverine Garnier et al.
Genome Medicine, 2021, 13 (1), pp.87. ⟨10.1186/s13073-021-00897-9⟩
Article dans une revue hal-03583277 v1

Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer

Ana Oaknin , Anna Tinker , Lucy Gilbert , Vanessa Samouëlian , Cara Mathews et al.
Future Oncology, 2021, 17 (29), pp.3781-3785. ⟨10.2217/fon-2021-0598⟩
Article dans une revue hal-03622744 v1
Image document

Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database

Alexandre de Nonneville , Christophe Zemmour , Sophie Frank , Florence Joly , Isabelle Ray-Coquard et al.
Gynecologic Oncology, 2021, 163 (1), pp.64-71. ⟨10.1016/j.ygyno.2021.07.019⟩
Article dans une revue hal-03622742 v1
Image document

TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients

Cecile Vicier , Patrick Sfumato , Nicolas Isambert , Florence Dalenc , Marie Robert et al.
European Journal of Cancer, 2021, 159, pp.205 - 214. ⟨10.1016/j.ejca.2021.09.040⟩
Article dans une revue inserm-03647613 v1
Image document

The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer

Leonel Varela Cagetti , Laurence Gonzague-Casabianca , Christophe Zemmour , Eric Lambaudie , Gilles Houvenaeghel et al.
Gynecologic Oncology, 2021, 161 (1), pp.166 - 172. ⟨10.1016/j.ygyno.2021.01.034⟩
Article dans une revue inserm-03649584 v1

739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial

Renaud Sabatier , Cécile Vicier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia et al.
Annals of Oncology, 2021, 32 (15_suppl), pp.S737-S738. ⟨10.1016/j.annonc.2021.08.1181⟩
Article dans une revue hal-03622737 v1
Image document

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer

Renaud Sabatier , Johan Martin , Cécile Vicier , Mathilde Guérin , Audrey Monneur et al.
Journal of Clinical Medicine, 2021, 10 (6), pp.1272. ⟨10.3390/jcm10061272⟩
Article dans une revue hal-03622759 v1
Image document

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial

Renaud Sabatier , Jean-Yves Pierga , Hervé Curé , Rakan Abulnaja , Eric Lambaudie et al.
Cancers, 2021, 13 (1), pp.140. ⟨10.3390/cancers13010140⟩
Article dans une revue hal-03622751 v1

Circulating tumor DNA as a noninvasive marker of resectability in ovarian carcinomas.

Roxane Mari , Christophe Pomel , Pierre-Emmanuel Colombo , Fabrice Narducci , Séverine Garnier et al.
Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.5548-5548. ⟨10.1200/JCO.2021.39.15_suppl.5548⟩
Article dans une revue hal-03622754 v1

TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients

Cecile Vicier , Patrick Sfumato , Nicolas Isambert , Florence Dalenc , Marie Robert et al.
European Journal of Cancer, 2021, 159, pp.205-214. ⟨10.1016/j.ejca.2021.09.040⟩
Article dans une revue hal-03622797 v1

Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer

Ana Oaknin , Anna Tinker , Lucy Gilbert , Vanessa Samouëlian , Cara Mathews et al.
Future Oncology, 2021, 17 (29), pp.3781-3785. ⟨10.2217/fon-2021-0598⟩
Article dans une revue hal-03623657 v1

Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

Ana Oaknin , Anna Tinker , Lucy Gilbert , Vanessa Samouëlian , Cara Mathews et al.
JAMA oncology, 2020, 6 (11), pp.1766. ⟨10.1001/jamaoncol.2020.4515⟩
Article dans une revue hal-03622783 v1

Nouvelles AMMs au niveau européen : alpélisib – cancer du sein RH+/HER2− métastatique avec mutation PIK3CA

Pauline Corbaux , Renaud Sabatier
Bulletin du Cancer, 2020, 107 (10), pp.959-960. ⟨10.1016/j.bulcan.2020.07.007⟩
Article dans une revue hal-03622832 v1
Image document

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?

Essia Mezni , Cécile Vicier , Mathilde Guerin , Renaud Sabatier , François Bertucci et al.
Cancers, 2020, 12 (6), pp.1573. ⟨10.3390/cancers12061573⟩
Article dans une revue hal-03623669 v1

Prediction of early discharge after gynaecological oncology surgery within ERAS

Eric Lambaudie , Jérome Mathis , Christophe Zemmour , Camille Jauffret-Fara , Elie Toni Mikhael et al.
Surgical Endoscopy, 2020, 34 (5), pp.1985-1993. ⟨10.1007/s00464-019-06974-w⟩
Article dans une revue inserm-03009273 v1
Image document

Florilège des actualités oncologiques internationales en 2019

Nicolas Magné , Renaud Sabatier , Marie Wislez , Thierry André , Manuel Rodrigues et al.
Bulletin du Cancer, 2020, 107 (2), pp.148-156. ⟨10.1016/j.bulcan.2020.01.010⟩
Article dans une revue hal-02518020 v1

High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer

Renaud Sabatier , Marc Lopez , Arnaud Guille , Emilien Billon , Nadine Carbuccia et al.
JCO precision oncology, 2019, 3, pp.1-8. ⟨10.1200/po.18.00310⟩
Article dans une revue hal-03623686 v1

Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort

Florence Daviet , Franck Rouby , Pascale Poullin , Julie Moussi‐francès , Marion Sallée et al.
British Journal of Clinical Pharmacology, 2019, 85 (2), pp.403-412. ⟨10.1111/bcp.13808⟩
Article dans une revue hal-02120988 v1
Image document

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Roxane Mari , Emilie Mamessier , Eric Lambaudie , Magali Provansal , Daniel Birnbaum et al.
Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩
Article dans une revue hal-03606425 v1
Image document

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Roxane Mari , Emilie Mamessier , Eric Lambaudie , Magali Provansal , Daniel Birnbaum et al.
Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩
Article dans une revue (article de synthèse) hal-02152656 v1
Image document

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

Renaud Sabatier , Emmanuelle Charafe-Jauffret , Jean-Yves Pierga , Hervé Curé , Eric Lambaudie et al.
Journal of Clinical Medicine Research, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩
Article dans une revue hal-02145624 v1

Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B

Lorène Seguin , Max Chaffanet , Séverine Garnier , José Adélaïde , Nadine Carbuccia et al.
JCO precision oncology, 2019, 3, pp.1-9. ⟨10.1200/po.18.00362⟩
Article dans une revue hal-03623688 v1

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

D. Moro-Sibilot , N. Cozic , M. Pérol , J. Mazieres , J. Otto et al.
Annals of Oncology, 2019, 30 (12), pp.1985-1991. ⟨10.1093/annonc/mdz407⟩
Article dans une revue hal-02530381 v1
Image document

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review

Gabrielle Planes-Laine , Philippe Rochigneux , François Bertucci , Anne-Sophie Chrétien , Patrice Viens et al.
Cancers, 2019, 11 (7), pp.1033. ⟨10.3390/cancers11071033⟩
Article dans une revue (article de synthèse) hal-02533030 v1

Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study

R. Sabatier , C. Pomel , P-E. Colombo , F. Narducci , S. Garnier et al.
Annals of Oncology, 2018, 29 (6), pp.3. ⟨10.1093/annonc/mdy316.007⟩
Article dans une revue hal-02143654 v1

RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer

R. Sabatier , S. Garnier , N. Carbuccia , A. Guille , C. Tarpin et al.
Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy316.001⟩
Article dans une revue hal-02143655 v1
Image document

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Emanuel Nicolas , François Bertucci , Renaud Sabatier , Anthony Gonçalves
Cancers, 2018, 10 (12), pp.506. ⟨10.3390/cancers10120506⟩
Article dans une revue hal-03669695 v1
Image document

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Renaud Sabatier , Véronique Diéras , Xavier B. Pivot , Etienne Brain , Henri Roche et al.
Breast Cancer Research and Treatment, 2018, 50 (4), pp.1226-1237. ⟨10.4143/crt.2017.446⟩
Article dans une revue inserm-01985845 v1

Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer

Renaud Sabatier , Emanuel Nicolas , Maria Paciencia , Annie-Pierre Jonville-Bera , Anne Madroszyk et al.
Journal of Geriatric Oncology, 2018, 9 (5), pp.494-500. ⟨10.1016/j.jgo.2018.02.011⟩
Article dans une revue hal-02143604 v1

A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine

L. Seguin , M. Chaffanet , R. Sabatier , A. Jose , S. Garnier et al.
Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy314.030⟩
Article dans une revue hal-02143656 v1

Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care

Alexandre de Nonneville , François Bertucci , Pascal Finetti , D. Perrot , M. Nilbert et al.
BMC Palliative Care, 2018, 17 (1), pp.104. ⟨10.1186/s12904-018-0357-6⟩
Article dans une revue hal-03583406 v1
Image document

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

Mathilde Guérin , Anthony Gonçalves , Yves Toiron , Emilie Baudelet , Matthieu Pophillat et al.
Oncotarget, 2018, 9 (73), pp.33762-33777. ⟨10.18632/oncotarget.26031⟩
Article dans une revue hal-02145636 v1

Safety and efficacy of eribulin for ``real-world'' older patients with metastatic breast cancer

Alexandre De Nonneville , Renaud Sabatier , Anthony Goncalves , Jean-Marc Extra , Carole Tarpin et al.
Journal of Geriatric Oncology, 2018, 9 (3), pp.281-283. ⟨10.1016/j.jgo.2017.11.003⟩
Article dans une revue hal-02143579 v1
Image document

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Emanuel Nicolas , Francois Bertucci , Renaud Sabatier , Anthony Goncalves
Cancers, 2018, 10 (12), ⟨10.3390/cancers10120506⟩
Article dans une revue hal-02143625 v1

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Laurys Boudin , Christian Chabannon , Patrick Sfumato , Renaud Sabatier , François Bertucci et al.
Bulletin du Cancer, 2017, 104 (4), pp.332 - 343. ⟨10.1016/j.bulcan.2016.12.007⟩
Article dans une revue hal-01788977 v1

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer

Mathilde Guerin , Keyvan Rezai , Nicolas Isambert , Mario Campone , Aurélie Autret et al.
European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
Article dans une revue hal-03623711 v1

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

Alexandre de Nonneville , Anthony Gonçalves , Christophe Zemmour , Jean Classe , Monique Cohen et al.
Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Article dans une revue hal-03623719 v1
Image document

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

Laurys Boudin , Anthony Gonçalves , Patrick Sfumato , Renaud Sabatier , François Bertucci et al.
American Journal of Cancer, 2016, 7 (14), pp.2077-2084. ⟨10.7150/jca.15797⟩
Article dans une revue inserm-01987531 v1

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

Anthony Gonçalves , François Bertucci , Arnaud Guille , Severine Garnier , José Adelaide et al.
Oncotarget, 2016, 7 (48), pp.79428-79441. ⟨10.18632/oncotarget.12714⟩
Article dans une revue hal-03623724 v1

Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]

Laurys Boudin , Christian Chabannon , Patrick Sfumato , Renaud Sabatier , François Bertucci et al.
European Journal of Cancer, 2016, 67, pp.223. ⟨10.1016/j.ejca.2016.09.002⟩
Article dans une revue hal-03623727 v1

Prognostic and predictive value of PDL1 expression in breast cancer

Renaud Sabatier , Pascal Finetti , Emilie Mamessier , José Adelaide , Max Chaffanet et al.
Oncotarget, 2015, 6 (7), pp.5449-5464. ⟨10.18632/oncotarget.3216⟩
Article dans une revue hal-03583484 v1

Stealth" tumors: Breast cancer cells shun NK-cells anti-tumor immunity

Emilie Mamessier , François Bertucci , Renaud Sabatier , Daniel Birnbaum , Daniel Olive
OncoImmunology, 2014, 1 (3), pp.366-368. ⟨10.4161/onci.18528⟩
Article dans une revue hal-03583489 v1
Image document

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

Renaud Sabatier , Pascal Finetti , Arnaud Guille , José Adelaïde , Max Chaffanet et al.
Molecular Cancer, 2014, 13, pp.228. ⟨10.2174/156652412798376134⟩
Article dans une revue inserm-01192813 v1

The CINSARC signature: Prognostic and predictive of response to chemotherapy?

François Bertucci , Pascal Finetti , Renaud Sabatier , Daniel Birnbaum
Cell Cycle, 2014, 9 (19), pp.4025-4027. ⟨10.4161/cc.9.19.13463⟩
Article dans une revue hal-03623803 v1

Personalized medicine: Present and future of breast cancer management

Renaud Sabatier , Anthony Gonçalves , François Bertucci
Critical Reviews in Oncology/Hematology, 2014, 91 (3), pp.223-233. ⟨10.1016/j.critrevonc.2014.03.002⟩
Article dans une revue hal-03623758 v1

Cancer du sein triple-négatif : caractéristiques histocliniques et moléculaires, prise en charge et perspectives thérapeutiques

Anthony Gonçalves , Renaud Sabatier , Emmanuelle Charafe-Jauffret , Marine Gilabert , Magali Provansal et al.
Bulletin du Cancer, 2013, 100 (5), pp.453-464. ⟨10.1684/bdc.2013.1740⟩
Article dans une revue hal-03623766 v1
Image document

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Renaud Sabatier , Anthony Gonçalves , François Bertucci , Maria-Antonietta Capiello , Frédérique Rousseau et al.
Journal of Experimental and Clinical Cancer Research, 2012, 31 (1), pp.87. ⟨10.1186/1756-9966-31-87⟩
Article dans une revue inserm-00765646 v1

Breast Metastasis of a Squamous Cell Carcinoma of the Uterine Cervix Mimicking Inflammatory Breast Cancer

Renaud Sabatier , Céline Roussin , Jean-Pierre Riviere , Aurélie Jalaguier , Jocelyne Jacquemier et al.
Case Reports in Oncology, 2012, 5 (2), pp.464-470. ⟨10.1159/000342255⟩
Article dans une revue hal-03623778 v1

Are we turning to more than a first line treatment of metastatic colorectal cancer with high dose irinotecan?: A monocentric institution safety analysis of 46 patients

L. Mineur , R. Sabatier , S. Kirscher , F. Plat , Y. Goubely et al.
Clinics and Research in Hepatology and Gastroenterology, 2011, 35 (2), pp.125-131. ⟨10.1016/j.gcb.2009.11.005⟩
Article dans une revue istex hal-02649856 v1
Image document

Kinome expression profiling and prognosis of basal breast cancers

Renaud Sabatier , Pascal Finetti , Emilie Mamessier , Stéphane Raynaud , Nathalie Cervera et al.
Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩
Article dans une revue hal-03606422 v1
Image document

Kinome expression profiling and prognosis of basal breast cancers.

Renaud Sabatier , Pascal Finetti , Emilie Mamessier , Stéphane Raynaud , Nathalie Cervera et al.
Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩
Article dans une revue inserm-00614833 v1

A seven-gene prognostic model for platinum-treated ovarian carcinomas

R Sabatier , Pascal Finetti , J Bonensea , J Jacquemier , J Adelaide et al.
British Journal of Cancer, 2011, 105 (2), pp.304-311. ⟨10.1038/bjc.2011.219⟩
Article dans une revue hal-03637781 v1

Peritumoural vascular invasion: A major determinant of triple-negative breast cancer outcome

Renaud Sabatier , Jocelyne Jacquemier , François Bertucci , Benjamin Esterni , Pascal Finetti et al.
European Journal of Cancer, 2011, 47 (10), pp.1537-1545. ⟨10.1016/j.ejca.2011.02.002⟩
Article dans une revue istex hal-03623796 v1

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

Renaud Sabatier , Pascal Finetti , José Adelaide , Arnaud Guille , Jean-Paul Borg et al.
PLoS ONE, 2011, 6 (11), pp.e27656. ⟨10.1371/journal.pone.0027656⟩
Article dans une revue hal-03623789 v1
Image document

A gene expression signature identifies two prognostic subgroups of basal breast cancer

Renaud Sabatier , Pascal Finetti , Nathalie Cervera , Eric Lambaudie , Benjamin Esterni et al.
Breast Cancer Research and Treatment, 2010, 126 (2), pp.407-420. ⟨10.1007/s10549-010-0897-9⟩
Article dans une revue hal-00583558 v1

BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer

Renaud Sabatier , José Adélaïde , Pascal Finetti , Anthony Ferrari , Laetitia Huiart et al.
Genes, Chromosomes & Cancer, 2010, 49 (12), pp.1143-1151. ⟨10.1002/gcc.20822⟩
Article dans une revue istex hal-03623799 v1
Image document

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

Renaud Sabatier , Corinne Bouvier , Gonzague de Pinieux , Anthony Sarran , Isabelle Brenot-Rossi et al.
BMC Cancer, 2010, 10, pp.645. ⟨10.1186/1471-2407-10-645⟩
Article dans une revue hal-00546735 v1

Une forme « ariditaire » du cancer de l’ovaire

David Birnbaum , Renaud Sabatier , Emilie Mamessier , Daniel Birnbaum , François Bertucci
Médecine/Sciences, 2010, 26 (12), pp.1040-1042. ⟨10.1051/medsci/201026121040⟩
Article dans une revue hal-03583491 v1
Image document

mRNA expression in human breast cancer: a meta-analysis

Anthony Gonçalves , Pascal Finetti , Renaud Sabatier , Marine Gilabert , José Adelaïde et al.
Breast Cancer Research and Treatment, 2010, 127 (1), pp.273-281. ⟨10.1007/s10549-010-1199-y⟩
Article dans une revue hal-00594471 v1

Gene expression profiling and prediction of clinical outcome in ovarian cancer

Renaud Sabatier , Pascal Finetti , Nathalie Cervera , Daniel Birnbaum , François Bertucci
Critical Reviews in Oncology/Hematology, 2009, 72 (2), pp.98-109. ⟨10.1016/j.critrevonc.2009.01.007⟩
Article dans une revue istex hal-03623817 v1